11 reports of this reaction
1.4% of all BARIUM SULFATE reports
#17 most reported adverse reaction
ABDOMINAL DISTENSION is the #17 most commonly reported adverse reaction for BARIUM SULFATE, manufactured by E-Z-EM Canada Inc. There are 11 FDA adverse event reports linking BARIUM SULFATE to ABDOMINAL DISTENSION. This represents approximately 1.4% of all 781 adverse event reports for this drug.
Patients taking BARIUM SULFATE who experience abdominal distension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABDOMINAL DISTENSION is a less commonly reported adverse event for BARIUM SULFATE, but still significant enough to appear in the safety profile.
In addition to abdominal distension, the following adverse reactions have been reported for BARIUM SULFATE:
The following drugs have also been linked to abdominal distension in FDA adverse event reports:
ABDOMINAL DISTENSION has been reported as an adverse event in 11 FDA reports for BARIUM SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABDOMINAL DISTENSION accounts for approximately 1.4% of all adverse event reports for BARIUM SULFATE, making it a notable side effect.
If you experience abdominal distension while taking BARIUM SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.